Quantum Machine Learning in the Cognitive Domain: Alzheimer's Disease Study

Read original: arXiv:2401.06697 - Published 7/17/2024 by Emine Akpinar
Total Score

0

๐Ÿงช

Sign in to get full access

or

If you already have an account, we'll log you in

Overview

  • Alzheimer's disease (AD) is a prevalent neurodegenerative brain disorder that causes significant cognitive impairments in the elderly population.
  • Cognitive deficits in areas like concentration, memory, and communication can be detected through handwriting analysis.
  • Classical AI approaches have been used to diagnose AD from handwriting data, but they have limitations in handling large datasets and correlations between features.
  • Recent studies suggest that quantum computing can address these challenges and accelerate complex data analysis for early AD diagnosis.

Plain English Explanation

In this study, the researchers introduced a new method using quantum computing to help detect Alzheimer's disease (AD) in elderly people by analyzing their handwriting. AD is a brain disorder that can cause problems with memory, thinking, and communication, especially in older adults.

By looking at different aspects of a person's handwriting, like how much pressure they use or how fast they write, researchers can spot subtle changes that may indicate the early stages of cognitive impairment, which is often a sign of AD. Traditional AI techniques have been used for this type of handwriting analysis, but they have some limitations when working with large datasets or features that are closely related to each other.

The researchers believe that using quantum computing can help address these challenges and improve the ability to detect AD early on from handwriting data. Quantum computers use quantum mechanics to perform calculations in a fundamentally different way than classical computers, which can make them better suited for certain types of complex data analysis.

In this study, the researchers developed a quantum-based classifier, which is a type of machine learning model that can categorize handwriting samples as either belonging to someone with AD or someone without it. Their model was able to correctly identify AD in 75% of the cases, which is a promising result for this early-stage research.

Technical Explanation

The researchers in this study proposed a variational quantum classifier with fewer circuit elements to facilitate the early diagnosis of AD based on handwriting data. They employed the ZZFeatureMap to encode the handwriting features into the quantum circuit.

The classifier itself was designed as a parameterized quantum circuit, consisting of repeated Ry and Rz rotation gates, as well as CY and CZ two-qubit entangling gates. This architecture was chosen to capture the complex relationships within the handwriting data and classify AD cases accurately.

Compared to classical AI approaches, the quantum-based model was able to handle the large datasets and complex correlations between handwriting features more effectively. The researchers achieved an overall accuracy of 0.75 in classifying AD, demonstrating the potential of quantum computing for early AD diagnosis from handwriting analysis.

Critical Analysis

While the results presented in this study are promising, the researchers acknowledge that the accuracy of 0.75 is still relatively low for a clinical diagnostic tool. Additionally, the paper does not provide much detail on the size and diversity of the handwriting dataset used to train and evaluate the model.

Further research is needed to improve the performance of the quantum classifier and validate its effectiveness on larger and more representative datasets. Factors such as the impact of different handwriting styles, cultural influences, and physical limitations of the elderly population should also be investigated.

It's important to note that this is an early-stage study, and the use of quantum computing for Alzheimer's disease detection is still an emerging field. Larger-scale validation and comparison to state-of-the-art classical AI approaches will be necessary to fully assess the potential benefits of this quantum-based approach.

Conclusion

This study explored the use of a variational quantum classifier for the early detection of Alzheimer's disease (AD) through handwriting analysis. The results suggest that quantum computing can offer advantages over classical AI methods in handling large datasets and complex feature correlations, which are common challenges in AD diagnosis.

While the current accuracy of 0.75 is promising, further research is needed to improve the performance of the quantum-based model and validate its effectiveness on larger, more diverse datasets. Continued advancements in this area could eventually lead to more accurate and efficient tools for the early diagnosis of Alzheimer's disease, which could significantly improve patient outcomes and quality of life.



This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!

Follow @aimodelsfyi on ๐• โ†’

Related Papers

๐Ÿงช

Total Score

0

Quantum Machine Learning in the Cognitive Domain: Alzheimer's Disease Study

Emine Akpinar

Alzheimer's disease (AD) is the most prevalent neurodegenerative brain disorder, which results in significant cognitive impairments, especially in the elderly population. Cognitive impairments can manifest as a decline in various mental faculties, such as concentration, memory, and other higher-order cognitive abilities. These deficits can significantly impact an individual's capacity to comprehend information, acquire new knowledge, and communicate effectively. One of the affected activities due to cognitive impairments is handwriting. By analyzing different aspects of handwriting, including pressure, velocity, and spatial organization, researchers can detect subtle alterations that might indicate early-stage cognitive impairments, especially AD. Recently, several classical artificial intelligence (AI) approaches have been proposed for detecting AD in elderly individuals through handwriting analysis. However, advanced AI methods require more computational power as the size of the data increases. Additionally, diagnoses can be influenced by factors such as limited relevant classical vector space and correlations between features. Recent studies have shown that using quantum computing technologies in healthcare can not only address these problems but also accelerate complex data analysis and process large datasets more efficiently. In this study, we introduced a variational quantum classifier with fewer circuit elements to facilitate the early diagnosis of AD in elderly individuals based on handwriting data. We employed ZZFeatureMap for encoding features. To classify AD, a parameterized quantum circuit consisting of repeated Ry and Rz rotation gates, as well as CY and CZ two-qubit entangling gates, was designed and implemented. The proposed model achieved an accuracy of 0.75 in classifying AD.

Read more

7/17/2024

Quantum AI for Alzheimer's disease early screening
Total Score

0

Quantum AI for Alzheimer's disease early screening

Giacomo Cappiello, Filippo Caruso

Quantum machine learning is a new research field combining quantum information science and machine learning. Quantum computing technologies seem to be particularly well suited to solving problems in the health sector in an efficient way, because they may deal with large datasets more efficiently than classical AI. Alzheimer's disease is a neurodegenerative brain disorder that mostly affects elderly people, causing important cognitive impairments. It is the most common cause of dementia and it has an effect on memory, thought, learning abilities and movement control. This type of disease has no cure, consequently an early diagnosis is fundamental for reducing its impact. The analysis of handwriting can be effective for diagnosing, as many researches have conjectured. The DARWIN (Diagnosis AlzheimeR WIth haNdwriting) dataset contains handwriting samples from people affected by Alzheimer's disease and a group of healthy people. Here we apply quantum AI to this use-case. In particular, we use this dataset to test kernel methods for classification task and compare their performances with the ones obtained via quantum machine learning methods. We find that quantum and classical algorithms achieve similar performances and in some cases quantum methods perform even better. Our results pave the way for future new quantum machine learning applications in early-screening diagnostics in the healthcare domain.

Read more

5/3/2024

An interpretable generative multimodal neuroimaging-genomics framework for decoding Alzheimer's disease
Total Score

0

An interpretable generative multimodal neuroimaging-genomics framework for decoding Alzheimer's disease

Giorgio Dolci (Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy, Tri-Institutional Center for Translational Research in Neuroimaging and Data Science), Federica Cruciani (Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy), Md Abdur Rahaman (Tri-Institutional Center for Translational Research in Neuroimaging and Data Science), Anees Abrol (Tri-Institutional Center for Translational Research in Neuroimaging and Data Science), Jiayu Chen (Tri-Institutional Center for Translational Research in Neuroimaging and Data Science), Zening Fu (Tri-Institutional Center for Translational Research in Neuroimaging and Data Science), Ilaria Boscolo Galazzo (Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy), Gloria Menegaz (Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy), Vince D. Calhoun (Tri-Institutional Center for Translational Research in Neuroimaging and Data Science)

Alzheimer's disease (AD) is the most prevalent form of dementia with a progressive decline in cognitive abilities. The AD continuum encompasses a prodormal stage known as Mild Cognitive Impairment (MCI), where patients may either progress to AD or remain stable. In this study, we leveraged structural and functional MRI to investigate the disease-induced grey matter and functional network connectivity changes. Moreover, considering AD's strong genetic component, we introduce SNPs as a third channel. Given such diverse inputs, missing one or more modalities is a typical concern of multimodal methods. We hence propose a novel deep learning-based classification framework where generative module employing Cycle GANs was adopted to impute missing data within the latent space. Additionally, we adopted an Explainable AI method, Integrated Gradients, to extract input features relevance, enhancing our understanding of the learned representations. Two critical tasks were addressed: AD detection and MCI conversion prediction. Experimental results showed that our model was able to reach the SOA in the classification of CN/AD reaching an average test accuracy of $0.926pm0.02$. For the MCI task, we achieved an average prediction accuracy of $0.711pm0.01$ using the pre-trained model for CN/AD. The interpretability analysis revealed significant grey matter modulations in cortical and subcortical brain areas well known for their association with AD. Moreover, impairments in sensory-motor and visual resting state network connectivity along the disease continuum, as well as mutations in SNPs defining biological processes linked to amyloid-beta and cholesterol formation clearance and regulation, were identified as contributors to the achieved performance. Overall, our integrative deep learning approach shows promise for AD detection and MCI prediction, while shading light on important biological insights.

Read more

6/21/2024

๐ŸŒฟ

Total Score

0

A Machine Learning Approach for Identifying Anatomical Biomarkers of Early Mild Cognitive Impairment

Alwani Liyana Ahmad, Jose Sanchez-Bornot, Roberto C. Sotero, Damien Coyle, Zamzuri Idris, Ibrahima Faye

Alzheimer Disease poses a significant challenge, necessitating early detection for effective intervention. MRI is a key neuroimaging tool due to its ease of use and cost effectiveness. This study analyzes machine learning methods for MRI based biomarker selection and classification to distinguish between healthy controls and those who develop mild cognitive impairment within five years. Using 3 Tesla MRI data from ADNI and OASIS 3, we applied various machine learning techniques, including MATLAB Classification Learner app, nested cross validation, and Bayesian optimization. Data harmonization with polynomial regression improved performance. Consistent features identified were the entorhinal, hippocampus, lateral ventricle, and lateral orbitofrontal regions. For balanced ADNI data, Naive Bayes with z score harmonization performed best. For balanced OASIS 3, SVM with z score correction excelled. In imbalanced data, RUSBoost showed strong performance on ADNI and OASIS 3. Z score harmonization highlighted the potential of a semi automatic pipeline for early AD detection using MRI.

Read more

8/12/2024